FRESHAIR4Life: Building the Case for Action

NCT06074939 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1750

Last updated 2023-10-10

No results posted yet for this study

Summary

The goal of this observational study is to understand the burden and determinants of tobacco use and air pollution (AP) exposure among mid- to late adolescents in Greece, the Kyrgyz Republic, Pakistan, Romania, and Uganda. This context-specific knowledge will be crucial for selecting, adapting, and implementing preventive interventions in the next phase of the project.

The main questions the investigators aim to answer are:

* What is the perceived burden of tobacco use and AP exposure among adolescents?
* What are the contextual drivers and behavioral determinants contributing to (prevention of) these risk factors?
* How do the dynamics between stakeholders influence prevention efforts?

In this study, data will be collected through interviews, focus group discussions, photovoice, document analysis, observations, personal exposure monitoring, and questionnaires.

Conditions

  • Tobacco Use
  • Pollution; Exposure
  • Non-communicable Disease

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER
  • University of York

    collaborator OTHER
  • University of Edinburgh

    collaborator OTHER
  • The Initiative

    collaborator UNKNOWN
  • Lungs Europe

    collaborator UNKNOWN
  • International Primary Care Respiratory Group

    collaborator UNKNOWN
  • University of Groningen

    collaborator OTHER
  • University of Crete

    collaborator OTHER
  • Ministry of Health, Kyrgyzstan

    collaborator OTHER_GOV
  • Romanian Center for Studies in Family Medicine

    collaborator UNKNOWN
  • Makerere University

    collaborator OTHER
  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Rianne MJJ van der Kleij, PhD · Leiden University Medical Center

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-06-30
Completion
2024-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074939 on ClinicalTrials.gov